The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.
作者信息
McInnes G T
机构信息
University Department of Medicine, Gardiner Institute, Western Infirmary, Glasgow.
出版信息
Br J Clin Pharmacol. 1989 Mar;27(3):281-4. doi: 10.1111/j.1365-2125.1989.tb05365.x.
Abstract
摘要
相似文献
1
The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.治疗药物监测对执业医师的价值——一个有待检验的假设。
Br J Clin Pharmacol. 1989 Mar;27(3):281-4. doi: 10.1111/j.1365-2125.1989.tb05365.x.
2
[Clinical application of therapeutic drug monitoring (TDM)].治疗药物监测（TDM）的临床应用
Nihon Ika Daigaku Zasshi. 1992 Feb;59(1):2-8. doi: 10.1272/jnms1923.59.2.
3
Use of serum drug concentrations in surgical patients.血清药物浓度在外科患者中的应用。
Am J Surg. 1988 Jul;156(1):68-76. doi: 10.1016/s0002-9610(88)80176-4.
4
Therapeutic drug monitoring in childhood.儿童治疗药物监测
Aust Paediatr J. 1986 Feb;22(1):19-26. doi: 10.1111/j.1440-1754.1986.tb00177.x.
5
Therapeutic drug monitoring.
Clin Pharmacol Ther. 1988 Apr;43(4):345-53. doi: 10.1038/clpt.1988.42.
6
[Therapeutic monitoring of drug concentration in blood. Are the analyses correctly ordered?].[血液中药物浓度的治疗监测。分析顺序正确吗？]
Ugeskr Laeger. 1991 Apr 29;153(18):1281-4.
7
When should plasma drug levels be monitored?何时应监测血浆药物水平？
Drugs. 1979 Jun;17(6):488-500. doi: 10.2165/00003495-197917060-00005.
8
Plasma concentrations of drugs as a guide to therapy in clinical practice.
Ir Med J. 1978 Nov 30;71(17):578-82.
9
Drug level monitoring in paediatric practice.儿科临床中的药物浓度监测
Arch Dis Child. 1980 Feb;55(2):89-98. doi: 10.1136/adc.55.2.89.
10
[Dry clinical chemistry--analysis of drugs in blood].[干式临床化学——血液中药物分析]
Rinsho Byori. 1997 Nov;Suppl:83-8.
引用本文的文献
1
Moving Pharmacogenetics Into Practice: It's All About the Evidence!将药物遗传学付诸实践：关键在于证据！
Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327. Epub 2021 Jul 7.
2
Personalized Drug Dosage - Closing the Loop.个性化药物剂量——闭环。
Pharm Res. 2017 Aug;34(8):1539-1543. doi: 10.1007/s11095-016-2076-0. Epub 2016 Dec 9.
3
Research priorities in pharmacokinetics.药代动力学的研究重点。
Br J Clin Pharmacol. 2012 Jun;73(6):924-6. doi: 10.1111/j.1365-2125.2012.04238.x.
4
Overview of therapeutic drug monitoring.治疗药物监测概述。
Korean J Intern Med. 2009 Mar;24(1):1-10. doi: 10.3904/kjim.2009.24.1.1.
5
Therapeutic drug monitoring: do the improved outcomes justify the costs?治疗药物监测：改善的结果是否证明成本合理？
Clin Pharmacokinet. 2001;40(6):405-9. doi: 10.2165/00003088-200140060-00002.
6
Therapeutic drug monitoring beyond 2000.2000年以后的治疗药物监测。
Br J Clin Pharmacol. 1998 Aug;46(2):93-4. doi: 10.1046/j.1365-2125.1998.00771.x.
7
Pharmacokinetic optimisation of tricyclic antidepressant therapy.三环类抗抑郁药治疗的药代动力学优化
Clin Pharmacokinet. 1993 Apr;24(4):301-18. doi: 10.2165/00003088-199324040-00004.
8
Drug concentration monitoring. An approach to rational use.药物浓度监测：合理用药的一种方法。
Clin Pharmacokinet. 1993 Mar;24(3):187-94. doi: 10.2165/00003088-199324030-00001.
9
ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.药物治疗监测基础。充分利用血浆药物浓度测定。
BMJ. 1993 Jan 2;306(6869):48-51. doi: 10.1136/bmj.306.6869.48.
10
Therapeutic drug monitoring and patient outcome. A review of the issues.
Clin Pharmacokinet. 1994 Sep;27(3):169-74. doi: 10.2165/00003088-199427030-00001.
本文引用的文献
1
Serum phenytoin concentration and clinical response in patients with epilepsy.癫痫患者的血清苯妥英浓度及临床反应
Br J Clin Pharmacol. 1981 Dec;12(6):833-9. doi: 10.1111/j.1365-2125.1981.tb01316.x.
2
Modelling theophylline response in individual patients with chronic bronchitis.模拟慢性支气管炎个体患者的茶碱反应。
Br J Clin Pharmacol. 1981 Oct;12(4):481-7. doi: 10.1111/j.1365-2125.1981.tb01254.x.
3
Effect of theophylline pharmacokinetic monitoring service on cost and quality of care.茶碱药代动力学监测服务对医疗成本和质量的影响。
Am J Hosp Pharm. 1982 Oct;39(10):1656-62.
4
Interactions with digoxin: more problems.与地高辛的相互作用：更多问题。
Br Med J (Clin Res Ed). 1982 Jan 30;284(6312):291-2. doi: 10.1136/bmj.284.6312.291.
5
Phenytoin monotherapy for epilepsy: a long-term prospective study, assisted by serum level monitoring, in previously untreated patients.苯妥英单药治疗癫痫：一项针对既往未接受治疗患者的长期前瞻性研究，辅以血清水平监测。
Epilepsia. 1981 Aug;22(4):475-88. doi: 10.1111/j.1528-1157.1981.tb06158.x.
6
Impact of therapeutic audit on phenytoin prescribing.治疗性审核对苯妥英钠处方的影响。
Br Med J (Clin Res Ed). 1981 Apr 18;282(6272):1278. doi: 10.1136/bmj.282.6272.1278.
7
Serum concentration and clinical supervision in monitoring of lithium treatment.锂盐治疗监测中的血清浓度与临床监护
Ther Drug Monit. 1980;2(1):73-83. doi: 10.1097/00007691-198001000-00009.
8
Management of epilepsy.癫痫的管理
Br Med J (Clin Res Ed). 1984 Mar 31;288(6422):986-7. doi: 10.1136/bmj.288.6422.986.
9
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.临床药代动力学：治疗药物监测与处方的综合系统。
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):541-5. doi: 10.1136/bmj.288.6416.541.
10
Digitalis intoxication: a new approach to an old problem.洋地黄中毒：解决老问题的新方法。
Br Med J (Clin Res Ed). 1983 May 14;286(6377):1533-4. doi: 10.1136/bmj.286.6377.1533.
Zotero 插件